We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
Cap. Flow
-$179M
Cap. Flow %
-0.34%
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$67.7M
2
CTVA icon
Corteva
CTVA
+$33.4M
3
TCF
TCF Financial Corporation Common Stock
TCF
+$19.3M
4
SPOT icon
Spotify
SPOT
+$15.3M
5
AMCR icon
Amcor
AMCR
+$15M

Sector Composition

Rank Sector Weight
1 Technology 18.25%
2 Financials 15.55%
3 Healthcare 13.39%
4 Consumer Discretionary 10.43%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTE
2926
DELISTED
PolarityTE, Inc. Common Stock
PTE
$103K ﹤0.01%
720
+228
+46% +$43.2K
NEXT icon
2927
NextDecade
NEXT
$1.74B
$102K ﹤0.01%
16,205
+3,490
+27% +$19.4K
MUFG icon
2928
Mitsubishi UFJ Financial
MUFG
$246B
$101K ﹤0.01%
21,238
+232
+1% +$1.11K
RMNI icon
2929
Rimini Street
RMNI
$459M
$101K ﹤0.01%
19,125
+8,225
+75% +$41.5K
VSI
2930
DELISTED
Vitamin Shoppe Inc.
VSI
$101K ﹤0.01%
25,555
-1,211
-5% -$6.26K
XBIT icon
2931
XBiotech
XBIT
$68.3M
$100K ﹤0.01%
+13,221
New +$115K
SVRA icon
2932
Savara
SVRA
$1.11B
$95K ﹤0.01%
39,885
+3,581
+10% +$31.8K
AVTX icon
2933
Avalo Therapeutics
AVTX
$980M
$94K ﹤0.01%
+6
New +$90.9K
NTGN
2934
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$94K ﹤0.01%
19,870
+7,812
+65% +$43.7K
PSEC icon
2935
Prospect Capital
PSEC
$1.13B
$93K ﹤0.01%
14,177
+34
+0.2% +$225
IDEX
2936
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$93K ﹤0.01%
+301
New +$65.2K
NMR icon
2937
Nomura Holdings
NMR
$28.5B
$87K ﹤0.01%
24,446
SER icon
2938
Serina Therapeutics
SER
$32.1M
$80K ﹤0.01%
621
+235
+61% +$31.8K
CRK icon
2939
Comstock Resources
CRK
$3.91B
$79K ﹤0.01%
+14,154
New +$82.2K
EYPT icon
2940
EyePoint Inc
EYPT
$978M
$79K ﹤0.01%
+4,838
New +$81.4K
NIHD
2941
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$77K ﹤0.01%
45,382
-78,594
-63% -$150K
RTW
2942
DELISTED
RTW Retailwinds, Inc.
RTW
$76K ﹤0.01%
44,559
+5,209
+13% +$11.3K
FRE
2943
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$75K ﹤0.01%
28,948
SND icon
2944
Smart Sand
SND
$193M
$74K ﹤0.01%
30,518
+1,406
+5% +$4.99K
USWS
2945
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$73K ﹤0.01%
+725
New +$107K
VBIV
2946
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$71K ﹤0.01%
+2,024
New +$110K
EVFM
2947
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$70K ﹤0.01%
+707
New +$54.8K
CHRA
2948
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$66K ﹤0.01%
+1,200
New +$69.6K
EMWP
2949
DELISTED
Eros Media World PLC
EMWP
$66K ﹤0.01%
2,454
+126
+5% +$17K
TBHC
2950
DELISTED
The Brand House Collective
TBHC
$54K ﹤0.01%
23,704
-21,284
-47% -$100K

Similar funds

RhumbLine Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
  • RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
  • RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
  • RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
  • RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
  • RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.